Kayyem Jon Faiz
Director at Inhibrx, Inc.; SVP, Research & Development at GenMark Diagnostics, Inc.
- Sold, on record
- $4.2M
- Dollars the filings state
- Form 4 sales
- 58
- Latest Jan 23, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Inhibrx, Inc.Director
- GenMark Diagnostics, Inc.SVP, Research & Development
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- GenMark Diagnostics, Inc.249,761 shares
- Inhibrx, Inc.38,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale GenMark Diagnostics, Inc.Plan not statedNov 2, 2017 2017
Sold 135 shares at $7.24 ($977)
Kayyem Jon Faiz, SVP, Research & Development
Sold 0.1% of holdings ($1.4M position)199,174 shares left0.4x usual sizeFiling
- 2 Form 4 sale GenMark Diagnostics, Inc.UnusualNov 20, 2017 +18 days
Sold 1,269 shares at $4.74 ($6k)
Kayyem Jon Faiz, SVP, Research & Development
Sold 0.6% of holdings ($944k position)197,905 shares left5.7x usual sizeFiling
- 3 Form 4 sale GenMark Diagnostics, Inc.Plan not statedDec 4, 2017 +14 days
Sold 135 shares at $4.70 ($635)
Kayyem Jon Faiz, SVP, Research & Development
Sold 0.1% of holdings ($930k position)197,770 shares left0.6x usual sizeFiling
- 4 Form 4 sale GenMark Diagnostics, Inc.Plan not statedFeb 2, 2018 +60 days
Sold 148 shares at $5.13 ($759)
Kayyem Jon Faiz, SVP, Research & Development
Sold 0.1% of holdings ($1M position)197,622 shares left1.1x usual sizeFiling
- 5 Form 4 sale Inhibrx, Inc.Plan not statedOct 21, 2022 +1722 days
Sold 9,500 shares at $30.13 ($286k)
Kayyem Jon Faiz, Director
Sold 0.3% of holdings ($98.3M position)3.3M shares leftFirst sale on recordFiling
- 6 Form 4 sale Inhibrx, Inc.Plan not statedNov 21, 2022 +31 days
Sold 9,500 shares at $29.89 ($284k)
Kayyem Jon Faiz, Director
Sold 0.3% of holdings ($97.2M position)3.2M shares leftFiling
- 7 Form 4 sale Inhibrx, Inc.Plan not statedDec 21, 2022 +30 days
Sold 9,500 shares at $27.02 ($257k)
Kayyem Jon Faiz, Director
Sold 0.3% of holdings ($87.6M position)3.2M shares leftFiling
- 8 Form 4 sale Inhibrx, Inc.Plan not statedJan 23, 2023 +33 days
Sold 9,500 shares at $25.26 ($240k)
Kayyem Jon Faiz, Director
Sold 0.3% of holdings ($81.7M position)3.2M shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (58)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Jan 23, 2023 | Inhibrx, Inc. | Director | Form 4 sale | 9,500 | $240k | 0.3% | Plan not stated | SEC |
| Dec 21, 2022 | Dec 22, 2022 | Inhibrx, Inc. | Director | Form 4 sale | 9,500 | $257k | 0.3% | Plan not stated | SEC |
| Nov 21, 2022 | Nov 22, 2022 | Inhibrx, Inc. | Director | Form 4 sale | 9,500 | $284k | 0.3% | Plan not stated | SEC |
| Oct 21, 2022 | Oct 24, 2022 | Inhibrx, Inc. | Director | Form 4 sale | 9,500 | $286k | 0.3% | Plan not stated | SEC |
| Feb 2, 2018 | Feb 6, 2018 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 148 | $759 | 0.1% | Plan not stated | SEC |
| Dec 4, 2017 | Dec 6, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 135 | $635 | 0.1% | Plan not stated | SEC |
| Nov 20, 2017 | Nov 21, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,269 | $6k | 0.6% | Unusual | SEC |
| Nov 2, 2017 | Nov 3, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 135 | $977 | 0.1% | Plan not stated | SEC |
| Sep 5, 2017 | Sep 6, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 133 | $1k | 0.1% | Plan not stated | SEC |
| Aug 21, 2017 | Aug 23, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,277 | $12k | 0.6% | Unusual | SEC |
| Aug 2, 2017 | Aug 4, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 138 | $1k | 0.1% | Plan not stated | SEC |
| Jun 2, 2017 | Jun 5, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 132 | $2k | 0.1% | Plan not stated | SEC |
| May 19, 2017 | May 23, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,265 | $16k | 0.6% | Unusual | SEC |
| May 2, 2017 | May 4, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 133 | $2k | 0.1% | Plan not stated | SEC |
| Mar 7, 2017 | Mar 9, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 311 | $4k | 0.2% | Plan not stated | SEC |
| Mar 3, 2017 | Mar 3, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 131 | $2k | 0.1% | Plan not stated | SEC |
| Feb 21, 2017 | Feb 21, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 5,250 | $53k | 3.3% | Unusual | SEC |
| Feb 2, 2017 | Feb 3, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 131 | $2k | 0.1% | Plan not stated | SEC |
| Jan 19, 2017 | Jan 20, 2017 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 5,718 | $71k | 3.5% | Unusual | SEC |
| Dec 7, 2016 | Dec 9, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 313 | $3k | 0.2% | Plan not stated | SEC |
| Dec 2, 2016 | Dec 6, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 132 | $1k | 0.1% | Plan not stated | SEC |
| Nov 2, 2016 | Nov 4, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 135 | $1k | 0.1% | Plan not stated | SEC |
| Sep 7, 2016 | Sep 9, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 310 | $3k | 0.2% | Plan not stated | SEC |
| Sep 2, 2016 | Sep 6, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 133 | $1k | 0.1% | Plan not stated | SEC |
| Aug 2, 2016 | Aug 4, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 135 | $1k | 0.1% | Plan not stated | SEC |
| Jun 7, 2016 | Jun 7, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 435 | $4k | 0.3% | Plan not stated | SEC |
| May 2, 2016 | May 4, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 135 | $782 | 0.1% | Plan not stated | SEC |
| Mar 7, 2016 | Mar 9, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 364 | $2k | 0.2% | Plan not stated | SEC |
| Mar 2, 2016 | Mar 3, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,542 | $8k | 1.0% | Plan not stated | SEC |
| Feb 3, 2016 | Feb 5, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,916 | $10k | 1.8% | Plan not stated | SEC |
| Jan 21, 2016 | Jan 25, 2016 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 78 | $530 | 0.1% | Plan not stated | SEC |
| Dec 8, 2015 | Dec 10, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 328 | $2k | 0.3% | Plan not stated | SEC |
| Dec 3, 2015 | Dec 4, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,321 | $10k | 1.3% | Plan not stated | SEC |
| Sep 11, 2015 | Sep 11, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 269 | $3k | 0.3% | Plan not stated | SEC |
| Sep 4, 2015 | Sep 4, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,158 | $11k | 1.1% | Plan not stated | SEC |
| Jun 16, 2015 | Jun 18, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 265 | $2k | 0.2% | Plan not stated | SEC |
| Jun 4, 2015 | Jun 5, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,042 | $10k | 1.0% | Plan not stated | SEC |
| Mar 11, 2015 | Mar 11, 2015 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 8,658 | $103k | 7.4% | Plan not stated | SEC |
| Dec 15, 2014 | Dec 17, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 325 | $4k | 0.3% | Plan not stated | SEC |
| Dec 4, 2014 | Dec 8, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,320 | $16k | 1.2% | Plan not stated | SEC |
| Oct 31, 2014 | Oct 31, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 6,000 | $66k | 6.7% | Plan not stated | SEC |
| Sep 12, 2014 | Sep 16, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 314 | $3k | 0.3% | Plan not stated | SEC |
| Sep 5, 2014 | Sep 9, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,506 | $15k | 1.4% | Plan not stated | SEC |
| Jul 1, 2014 | Jul 3, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 6,000 | $82k | 6.3% | Plan not stated | SEC |
| Jun 11, 2014 | Jun 13, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 291 | $3k | 0.3% | Plan not stated | SEC |
| Jun 5, 2014 | Jun 5, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,483 | $16k | 1.3% | Plan not stated | SEC |
| May 28, 2014 | May 30, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 6,000 | $66k | 5.9% | Plan not stated | SEC |
| Mar 11, 2014 | Mar 13, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,220 | $15k | 1.1% | Plan not stated | SEC |
| Mar 5, 2014 | Mar 6, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 7,355 | $92k | 6.9% | Plan not stated | SEC |
| Jan 16, 2014 | Jan 17, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 50,000 | $702k | 8.1% | Unusual | SEC |
| Jan 2, 2014 | Jan 6, 2014 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 106,000 | $1.4M | 14.6% | Unusual | SEC |
| Dec 4, 2013 | Dec 6, 2013 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,765 | $20k | 1.6% | Plan not stated | SEC |
| Oct 1, 2013 | Oct 3, 2013 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 6,000 | $73k | 5.3% | Plan not stated | SEC |
| Sep 3, 2013 | Sep 5, 2013 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,545 | $18k | 1.4% | Plan not stated | SEC |
| Aug 20, 2013 | Aug 22, 2013 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 1,310 | $13k | 1.2% | Plan not stated | SEC |
| Jul 1, 2013 | Jul 3, 2013 | GenMark Diagnostics, Inc. | SVP, Research & Development | Form 4 sale | 6,000 | $62k | 5.0% | Plan not stated | SEC |
| Apr 1, 2013 | Apr 3, 2013 | GenMark Diagnostics, Inc. | Chief Scientific Officer | Form 4 sale | 6,000 | $78k | 4.8% | Plan not stated | SEC |
| Mar 14, 2013 | Mar 18, 2013 | GenMark Diagnostics, Inc. | Chief Scientific Officer | Form 4 sale | 4,352 | $52k | 3.8% | Plan not stated | SEC |